SEC Filing Details

Document Details

Form
Filing Date
Feb 14, 2018
Document Date
Feb 12, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Innoviva, Inc.
Issuer
THERAVANCE INC
Filer
DiPaolo Mark

Copyright Nasdaq. Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.